Compared with the control group, study participants who supplemented with taurine had a significant improvement in the primary outcome of reducing risk of metabolic syndrome, demonstrated by the following weighted mean changes: systolic blood pressure - 4 mm Hg diastolic blood pressure -1.5 mm Hg triglycerides -18.3 mg/dL fasting blood glucose -5.9 mg/dL There were also significant improvements in secondary outcomes as shown by the following weighted mean changes: LDL cholesterol - 6.5 mg/dL total cholesterol - 8.3 mg/dL fasting insulin -1.52 IU/L HOMA-IR (calculation of insulin resistance) - 0.7 There was no significant effect on HDL, body weight, and BMI
How often will we meet to discuss dosage adjustments
As for patients with GERD, they may already be on treatment with acid suppression, allowing for longer persistence
You might benefit from a B12 shot if you: Follow a vegan or vegetarian diet
The epidemic of cardiovascular disease in the developing world: global implications
Federal regulations for advertising compounded drugs are less stringent than for FDA-approved drugs, though all prescription drug promotion by a manufacturer must be truthful, non-misleading, and accurate, according to the FDAs web page on compounding and the agency